Table 1.

Comparison Individuals in the HIV/chronic pain clinic with aberrant drug related behaviors and the HIV/chronic pain clinic overall

Variable*	With aberrant behaviors (N=37)	Without aberrant behaviors (N=100)	p-value
Age (median, IQR)	44 (37-49)	44 (39- 50)	0.66
Non-white race	18 (49%)	45 (45%)	0.85
Female	15 (41%)	25 (25%)	0.09
Transmission Risk Factor			0.04**
-Heterosexual	19 (51%)	32 (32%)
-Intravenous drug use	10 (27%)	22 (22%)
-Men who have sex with	8 (22%)	45 (45%)
men	0 (0%)	1 (1%)
-Other/unknown
Insurance			0.80
-Private	4 (11%)	16 (16%)
-Public	23 (62%)	57 (57%)
-None	10 (27%)	27 (27%)
CD4 (median, IQR)	327 (177-620)	386 (226- 662)	0.60
Viral loadundetectable	21 (57%)	54 (55%)	0.85
Pain (EuroQOL moderate/severe)	24 (80%)	72 (77%)	1.0
Functional impairment (EuroQOL, somewhat/unable to perform)	17 (55%)	41 (44%)
-mobility	2 (7%)	12 (13%)	0.31
-self-care	16 (53%)	47 (51%)	0.51
-usual activities			0.83
Depression (PHQ-9 ≥ 10)	10 (32%)	33 (36%)	0.83
Anxiety (PHQ- Anxiety=anxiety symptoms, panic)	10 (32%)	30 (33%)	1.0
Substance use (ASSIST)			0.53
-current	3 (10%)	5 (5%)
-prior	15 (50%)	53 (58%)
-never	12 (40%)	34 (37%)
Psychiatry/psychology visit	27 (73%)	74 ((74%)	1.0

^*Missing data: Race = 1, CD4 = 1, VL = 1, EuroQOL Pain = 14, EuroQOL Mobility = 13, EuroQOL Self-Care = 15, EuroQOL, Usual Activities = 14, PHQ-9 = 15, PHQ-Anxiety = 14, ASSIST = 15.

^**p-value < 0.05